NCT06216717 Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients
| NCT ID | NCT06216717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Neuropathic Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-13 |
| Primary Completion | 2025-03-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-13 with a primary completion date of 2025-03-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cortical stimulation has been used since 1991 to treat neuropathic pain. However, the underlying mechanisms are still incompletely understood and under-studied. In this protocol, the investigators aim to study the myeloarchitectonic and functional characteristics of areas activated by cortical epidural electrodes and to determine their relation to therapy response in chronic neuropathic refractory pain patients.
Eligibility Criteria
Inclusion Criteria * adults * patient implanted with a motor cortical stimulation system for chronic neuropathic refractory pain, * patient with available postoperative scanner Exclusion Criteria: None
Contact & Investigator
Petru ISAN
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Frequently Asked Questions
Who can join the NCT06216717 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Neuropathic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06216717 currently recruiting?
Yes, NCT06216717 is actively recruiting participants. Contact the research team at isan.p@chu-nice.fr for enrollment information.
Where is the NCT06216717 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT06216717 clinical trial?
NCT06216717 is sponsored by Centre Hospitalier Universitaire de Nice. The principal investigator is Petru ISAN at Centre Hospitalier Universitaire de Nice. The trial plans to enroll 100 participants.